L2FU® Launches New Corporate Website that Highlights its Successful Approach to Finding Clinical Study Patients Lost to Follow Up

PHILADELPHIA and LONDON, June 16, 2015 /PRNewswire/ -- L2FU^® (Lost to Follow Up), a global leader in the specialized area of locating clinical trial patients lost to follow up, has launched a new website that articulates its unique approach and expertise in the field.  

The L2FU site features case studies and a blog with useful tips and best practices for maintaining clinical trial integrity and minimizing missing data by locating patients lost to follow up quickly and efficiently. In addition to providing more information on L2FU services, the company's leadership team hopes the site can serve as a resource for optimizing clinical trial success.   

"L2FU has successfully located patients in more than 60 countries," says Hema Gadhia, Senior Operations Support Manager at L2FU.  "We have a proven success rate of 90 percent for L2FU searches. Lost patients undermine the success of your clinical trial. Our team recovers patients quickly and accurately by relying on proven processes and a secure, regulatory-compliant online portal. Finding patients lost to follow up can be complicated, but our new website presents our expertise and tools in a way that is easy to understand."

L2FU will continue to provide tips and best practices via its company blog. It also released its first guide to lost to follow up management, "Maintaining Clinical Trial Integrity & Minimizing Missing Data: The Official Guide To Lost To Follow Up Management," a comprehensive booklet that reflects its new brand image, as well as its dedication to helping clinical studies reduce the number of lost patients and, when necessary, recover them quickly. Download the guide by visiting L2FU.net and clicking "download the booklet" at the top of the page.

About L2FU^®
L2FU, an affiliate of MediciGroup^® Inc. is dedicated to finding patients for clinical trials. Working within strict privacy guidelines in more than 60 countries, the L2FU team proactively works with study sponsors, clinical sites and hospitals to swiftly recover patients and, consequently, potential missing data. Minimizing the number of lost patients in a study requires proactive development and implementation of programs that keep patients interested and coming back for study visits.

The L2FU team has years of experience in proactively recovering lost study subjects. It has access to many databases containing millions of vital records. As shown by the Tufts University Center for Drug Development, study coordinator workload has increased significantly. Thus, the services provided by the L2FU team are valued by sponsors, clinical research organizations (CROs) and research centers alike. Study sponsors retain L2FU services so that study coordinators can focus their time on patients still active in the study. L2FU's success in recovering lost patients ensures critical study data is accounted for.

For press inquiries please contact:

U.S. media contact:
Bernard Hall: +1-484-674-6816

Outside the U.S., media contact:
Elizabeth Puller +44 (0)208 834 1447

SOURCE L2FU

Related Links

https://l2fu.net